↓ Skip to main content

American Association for Cancer Research

The Effect of Photoimmunotherapy Followed by Liposomal Daunorubicin in a Mixed Tumor Model: A Demonstration of the Super-Enhanced Permeability and Retention Effect after Photoimmunotherapy

Overview of attention for article published in Molecular Cancer Therapeutics, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent
12 patents

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
41 Mendeley
Title
The Effect of Photoimmunotherapy Followed by Liposomal Daunorubicin in a Mixed Tumor Model: A Demonstration of the Super-Enhanced Permeability and Retention Effect after Photoimmunotherapy
Published in
Molecular Cancer Therapeutics, February 2014
DOI 10.1158/1535-7163.mct-13-0633
Pubmed ID
Authors

Kohei Sano, Takahito Nakajima, Peter L. Choyke, Hisataka Kobayashi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 20%
Student > Ph. D. Student 6 15%
Student > Doctoral Student 4 10%
Student > Master 4 10%
Student > Bachelor 4 10%
Other 5 12%
Unknown 10 24%
Readers by discipline Count As %
Medicine and Dentistry 7 17%
Biochemistry, Genetics and Molecular Biology 6 15%
Pharmacology, Toxicology and Pharmaceutical Science 5 12%
Agricultural and Biological Sciences 2 5%
Engineering 2 5%
Other 4 10%
Unknown 15 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2023.
All research outputs
#3,259,637
of 22,711,242 outputs
Outputs from Molecular Cancer Therapeutics
#506
of 3,860 outputs
Outputs of similar age
#41,508
of 310,134 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#13
of 55 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,860 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,134 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.